Shannon Elaine Mary — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Shannon Elaine Mary has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
According to the most recent SEC filing dated 2026-07-06, Shannon Elaine Mary is the President, Global Supply & Quality at Takeda Pharmaceutical Co Ltd. In this role, she oversees Takeda's global supply chain operations, manufacturing, quality assurance, and regulatory compliance for the company's pharmaceutical products. Public biographical information beyond the SEC filing is not readily available in this context; therefore, a formal background in education or prior positions is not established here. Takeda is a global biopharmaceutical company headquartered in Japan.
Role
Pres., Global Supply & Quality
Notability
45/100
Board memberships
Takeda Pharmaceutical Co Ltd
Awards & honors
Oversees global supply chain and quality for Takeda (as of 2026-07-06)
According to the most recent SEC filing dated 2026-07-06, Shannon Elaine Mary is the President, Global Supply & Quality at Takeda Pharmaceutical Co Ltd. In this role, she oversees Takeda's global supply chain operations, manufacturing, quality assurance, and regulatory compliance for the company's pharmaceutical products. Public biographical information beyond the SEC filing is…
How many SEC Form 4 filings has Shannon Elaine Mary submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Shannon Elaine Mary's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
